Flow cytometric analysis of FGL2 expression showed 1.7–11.5% FGL2 positive-staining glioma cells among disaggregated GSC neurospheres (Fig. 1b; Supplementary Figure 1). The gene discussed is FGL2; the disease is central nervous system cancer.